OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure
Diego J. Laderach, Daniel Compagno
Cancers (2021) Vol. 13, Iss. 18, pp. 4529-4529
Open Access | Times Cited: 14

Showing 14 citing articles:

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7

Inhibition of galectins in cancer: Biological challenges for their clinical application
Diego J. Laderach, Daniel Compagno
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 12

The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host–Pathogen Interactions
Bojana Stojanović, Bojan Stojanović, Jelena Milovanović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9617-9617
Open Access | Times Cited: 12

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6312-6312
Open Access | Times Cited: 16

Highlights on the Role of Galectin-3 in Colorectal Cancer and the Preventive/Therapeutic Potential of Food-Derived Inhibitors
Anna Aureli, Manuela Del Cornò, Beatrice Marziani, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 52-52
Open Access | Times Cited: 11

Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities
Ana Bogut, Bojan Stojanović, Marina Jovanović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15500-15500
Open Access | Times Cited: 6

Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
Yuanwei Shi, Danting Tang, Xiaoqi Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10

Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective
Henan Zhang, Junrui Wu, Na Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188989-188989
Closed Access | Times Cited: 3

Investigation of LGALS2 expression in the TCGA database reveals its clinical relevance in breast cancer immunotherapy and drug resistance
Song He, Zhong‐Hao Ji, Qing Zhang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2

RG-I-containing sugar domains from Centella Asiatica bind strongly to galectin-3 to inhibit cell–cell interactions
Xuejiao Xu, Zhen He, Xinlin Luo, et al.
Chemical and Biological Technologies in Agriculture (2024) Vol. 11, Iss. 1
Open Access

Galectins: a potential pharmacological target
V. A. Serebryakova, О. Е. Ваизова, E. L. Golovina, et al.
Bulletin of Siberian Medicine (2024) Vol. 23, Iss. 3, pp. 155-162
Open Access

Galectin-8 Immunohistochemical Profile in Pancreatic Ductal Adenocarcinoma: Emerging Evidence for Its Prognostic Role
Andreea Rusu, Irina-Draga Caruntu, Ludmila Lozneanu, et al.
Diagnostics (2023) Vol. 13, Iss. 20, pp. 3215-3215
Open Access | Times Cited: 1

Vascular Modulation of Antitumor Immunity: A Crosstalk Between Immune Cells and the Tumor Vasculature
Alexandru Mircea, Д. А. Зиновкин, Md Zahidul Islam Pranjol
Springer eBooks (2022), pp. 1-27
Closed Access | Times Cited: 1

Page 1

Scroll to top